underlying diagnoses were tetralogy of Fallot (n = 44, 33%) and pulmonary atresia +/-ventricular septal defect (n = 26, 19%). The most common previously employed conduit was a homograft (n = 91, 67%). Indications for PPVI included conduit stenosis (n = 75, 56%), regurgitation (n = 12, 9%) or mixed disease (n = 47, 35%). Immediate haemodynamic outcome was good; the peak stenotic gradient decreased from mean 40 mmHg to mean 11 mmHg (p = 0.047). Risk of severe procedural complication was low. There was one early post procedural death; due to device embolisation within the RVOT. In follow-up (median 21 months, range 0-98 months), there were two further deaths, unrelated to PPVI. Thirteen individuals developed IE (annualised incidence rate 4.6% per patient-year), 9 of these individuals required valve re-replacement. Two further individuals underwent valve replacement without IE.
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Conclusions: PPVI as performed in selected ANZ centres provides a relatively safe and feasible method of rehabilitating the RVOT. Background: Little is known about the impact of a coarctation repair on the functional outcomes of young adults. This study aimed to determine (1) the functional and mental health status of young adults with previous coarctation repair, and (2) the impact of late hypertension on their quality of life.
Methods: A cross-sectional study using validated selfreported questionnaires (Short Form 36 version 2 [SF-36v2], Beck Depression Inventory [BDI], and State-Trait Anxiety Inventory [STAI]) was performed in 54 patients aged 15-47 years with previous paediatric coarctation repair. Questionnaire scores were compared to healthy age-and gender-matched controls. Patients' previously published 24hour blood pressure monitoring results were included.
Results: Late hypertension was present in 64% (34/54) at a mean of 29 ± 8 years after coarctation repair. SF-36v2 mean physical component summary score was significantly lower in coarctation patients compared with controls (53.1 ± 6.8 vs. 56.0 ± 4.7, p = 0.02), but there was no significant difference in mean mental component summary score (p = 0.2). SF-36v2 mean role emotional score tended to be associated with 10 mmHg increases in mean 24-hour systolic blood pressure (regression coefficient 4.3, p = 0.06). STAI mean trait anxiety score tended to be higher in coarctation patients compared with controls (36.6 ± 9.0 vs. 33.5 ± 7.8, p = 0.06). There was no significant difference in BDI scores between patients and controls.
Conclusion: Young adults with previous coarctation repair report poorer physical health and higher anxiety compared to healthy controls. Strategies to improve self-reported physical health and anxiety should be explored. Long-term assessment of quality of life outcomes in coarctation patients is warranted. Objective: To examine the prevalence and predictors of psychological wellbeing among siblings of children, adolescents and adults with a Fontan circulation enrolled in the Australian and New Zealand Fontan Registry.
Methods: Siblings aged ≥6 years of patients enrolled in the ANZ Fontan Registry, who were at least 12 months post-Fontan completion were invited to complete a suite of validated psychometric instruments capturing a range of demographic, environmental and clinical factors.
Results: Eighty-two siblings from 63 families of patients enrolled in the ANZ Fontan Registry were included in this analysis. Siblings ranged in age from 6-45 years (M = 15, SD = 8.1), 52% were brothers, most (74%) were currently enrolled in primary of secondary schooling, 14% were in full-or part-time employment, and 10% had a university degree. Depressive symptoms requiring clinical intervention were reported by 38% of adult siblings, and 20% of child and adolescent siblings. Over one-quarter (29%) of adult siblings, and 16% of child and adolescent siblings, reported symptoms of anxiety warranting clinical assessment. Most participants (82%) reported feeling worried about their sibling's heart con-
